Literature DB >> 19951970

Diagnosis of platelet-type von Willebrand disease by flow cytometry.

Silvia Giannini1, Luca Cecchetti, Anna Maria Mezzasoma, Paolo Gresele.   

Abstract

Platelet-type von Willebrand disease (PT-VWD) is a rare autosomal dominant bleeding disorder which is due to a mutation in the gene encoding for platelet glycoprotein Ibalpha (GPIbalpha) resulting in enhanced affinity for von Willebrand factor (VWF). PT-VWD is often mistakenly diagnosed as type 2B VWD for the similarities between these two conditions. We characterized a new case of PT-VWD and evaluated the usefulness of a flow cytometric assay in the differential diagnosis between PT-VWD (n=1) and type 2B VWD (n=4). The flow cytometric assay was able to highlight the increased affinity of VWF for GPIbalpha as much as did RIPA and to differentiate the two diseases through mixing tests. Genetic analysis revealed a heterozygous point mutation in codon 239 of the GPIbalpha gene leading to a methionine to valine substitution (M239V). Flow cytometry represents a useful tool for the diagnosis of PT-VWD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19951970      PMCID: PMC2878803          DOI: 10.3324/haematol.2009.015990

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  18 in total

1.  Platelets release their lysosomal content in vivo in humans upon activation.

Authors:  S Ciferri; C Emiliani; G Guglielmini; A Orlacchio; G G Nenci; P Gresele
Journal:  Thromb Haemost       Date:  2000-01       Impact factor: 5.249

2.  Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease (VWD) from Type 2B VWD using a simplified ristocetin-induced-platelet-agglutination mixing assay and confirmed by genetic analysis.

Authors:  Emmanuel J Favaloro; David Patterson; Anna Denholm; Scott Mead; Ann Gilbert; Anne Collins; Jane Estell; Peter M George; Mark P Smith
Journal:  Br J Haematol       Date:  2007-10-03       Impact factor: 6.998

3.  Mutation in the gene encoding the alpha chain of platelet glycoprotein Ib in platelet-type von Willebrand disease.

Authors:  J L Miller; D Cunningham; V A Lyle; C N Finch
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

4.  Further characterization of platelet-type von Willebrand's disease in Japan.

Authors:  H Takahashi; M Handa; K Watanabe; Y Ando; R Nagayama; A Hattori; A Shibata; A B Federici; Z M Ruggeri; T S Zimmerman
Journal:  Blood       Date:  1984-12       Impact factor: 22.113

5.  A new case of acquired Glanzmann's thrombasthenia: diagnostic value of flow cytometry.

Authors:  S Giannini; A M Mezzasoma; G Guglielmini; R Rossi; E Falcinelli; P Gresele
Journal:  Cytometry B Clin Cytom       Date:  2008-05       Impact factor: 3.058

Review 6.  Genetics of type 2B von Willebrand disease: "true 2B," "tricky 2B," or "not 2B." What are the modifiers of the phenotype?

Authors:  Maha Othman; Emmanuel J Favaloro
Journal:  Semin Thromb Hemost       Date:  2008-11-28       Impact factor: 4.180

Review 7.  Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?

Authors:  Emmanuel J Favaloro
Journal:  Semin Thromb Hemost       Date:  2008-02       Impact factor: 4.180

8.  Dominant inheritance of a novel integrin beta3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families.

Authors:  Paolo Gresele; Emanuela Falcinelli; Silvia Giannini; Pio D'Adamo; Angela D'Eustacchio; Teresa Corazzi; Anna Maria Mezzasoma; Filomena Di Bari; Giuseppe Guglielmini; Luca Cecchetti; Patrizia Noris; Carlo L Balduini; Anna Savoia
Journal:  Haematologica       Date:  2009-03-31       Impact factor: 9.941

9.  Identification of a novel point mutation in platelet glycoprotein Ibalpha, Gly to Ser at residue 233, in a Japanese family with platelet-type von Willebrand disease.

Authors:  Y Matsubara; M Murata; K Sugita; Y Ikeda
Journal:  J Thromb Haemost       Date:  2003-10       Impact factor: 5.824

10.  Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.

Authors:  Silvia Giannini; Anna Maria Mezzasoma; Mario Leone; Paolo Gresele
Journal:  Haematologica       Date:  2007-12       Impact factor: 9.941

View more
  5 in total

Review 1.  von Willebrand disease.

Authors:  Paula D James; Anne C Goodeve
Journal:  Genet Med       Date:  2011-05       Impact factor: 8.822

2.  Analytical characterization and reference interval of an enzyme-linked immunosorbent assay for active von Willebrand factor.

Authors:  Lisa N van der Vorm; Li Li; Dana Huskens; Walid Chayouâ; Hilde Kelchtermans; Philip G de Groot; Mark Roest; Jasper A Remijn; Bas de Laat
Journal:  PLoS One       Date:  2019-02-13       Impact factor: 3.240

3.  Mechanisms of thrombocytopenia in platelet-type von Willebrand disease.

Authors:  Loredana Bury; Alessandro Malara; Stefania Momi; Eleonora Petito; Alessandra Balduini; Paolo Gresele
Journal:  Haematologica       Date:  2019-01-17       Impact factor: 9.941

4.  A p.Arg127Gln variant in GPIbα LRR5 allosterically enhances affinity for VWF: a novel form of platelet-type VWD.

Authors:  Loredana Bury; Emanuela Falcinelli; Haripriya Kuchi Bhotla; Anna Maria Mezzasoma; Giuseppe Guglielmini; Alexander Tischer; Laurie Moon-Tasson; Matthew Auton; Paolo Gresele
Journal:  Blood Adv       Date:  2022-04-12

5.  Platelet dysfunction in platelet-type von Willebrand disease due to the constitutive triggering of the Lyn-PECAM1 inhibitory pathway.

Authors:  Loredana Bury; Emanuela Falcinelli; Anna Maria Mezzasoma; Giuseppe Guglielmini; Stefania Momi; Paolo Gresele
Journal:  Haematologica       Date:  2022-07-01       Impact factor: 11.047

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.